Publications by authors named "Hyung Don Kook"
Article Synopsis
- * A case study of a 46-year-old male with AIDS revealed an erythematous patch on his forearm, which was ultimately diagnosed as an early patch stage of KS through histological analysis showing abnormal blood vessel growth and positive HHV-8 staining.
- * Early-stage KS can often be misdiagnosed due to its similar appearance to other conditions, highlighting the importance of accurate pathological assessment in HIV-positive patients with vascular lesions.
Tuberculous lymphadenitis is among the most frequent presentations of extrapulmonary tuberculosis; the most common presentation is isolated chronic non-tender lymphadenopathy in young adults without systemic symptoms. Dupilumab is a fully human monoclonal antibody directed against interleukin-4 receptor-α that blocks the synergistic effects of interleukin-4 and interleukin-13 on allergic inflammation. Its well-known adverse events are allergic conjunctivitis, injection site reaction, and dupilumab facial redness.
View Article and Find Full Text PDFBackground: Atopic dermatitis (AD) patients usually wonder if their condition will worsen after vaccination or if they should continue with the treatment they are receiving. Considering that many patients treated with dupilumab had previously experienced severe AD symptoms and flares, the concerns are more understandable.
Objective: This study aimed to investigate the safety of the coronavirus disease 2019 (COVID-19) vaccination in patients with AD treated with dupilumab.
Previously, we have reported short term effectiveness and safety of dupilumab in Korea. In this study, we are trying to report the long-term effectiveness and safety of dupilumab in Korea. Ninety-nine patients with moderate to severe AD were analyzed.
View Article and Find Full Text PDF